Are you currently evaluating the Enhancing Oncology Model (EOM) or other value-aligned payment programs? Canopy hosted a virtual panel discussion on strategies for the EOM and outcome-based care delivery, featuring thought leaders in community oncology:
Canopy, the first Intelligent Care Platform for oncology, today announced they will be presenting their research on the patient impact of their ePRO-based patient monitoring platform at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held June 3-7.
Canopy, the Intelligent Care Platform (ICP) for oncology, today announced it has raised$13 million in funding led by GSR Ventures, with participation from Samsung Next, UpWest, and other industry leaders and executives, such as Geoff Calkins (former SVP Product, Flatiron Health), and Chris Mansi (CEO Of Viz.AI). Formerly known as Expain, Canopy is also launching out of stealth today to make its platform generally available to cancer treatment centers across the U.S.